Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Friday, June 13, 2008
GSK's Witty and his "3D Plan"
GlaxoSmithKline will "diversify and derisk" the company to help provide strong fuel share price growth combined with and give investors fewer "nasty surprises", according to Andrew Witty, the new chief executive of Britain's biggest drugs company.